Pre-eclampsia: an Update

Overview

Journal Curr Hypertens Rep

Specialty Cardiology & Vascular Diseases

Date 2014 Jun 12

PMID 24915961

Citations 31

Authors

Peter von Dadelszen

Laura A Magee

Affiliations

Soon will be listed here.

Abstract

Pre-eclampsia remains the second leading direct cause of maternal death, >99 % of which occurs in less developed countries. Over 90 percent of the observed reduction in pre-eclampsia-related maternal deaths in the UK (1952-2008) occurred with antenatal surveillance and timed delivery. In this review, we discuss the pathogenesis, diagnostic criteria, disease prediction models, prevention and management of pre-eclampsia. The Pre-eclampsia Integrated Estimate of RiSk (PIERS) models and markers of angiogenic imbalance identify women at incremental risk for severe pre-eclampsia complications. For women at high risk of developing pre-eclampsia, low doses of aspirin (especially if started <17 weeks) and calcium are evidence-based preventative strategies; heparin is less so. Severe hypertension must be treated and the Control of Hypertension In Pregnancy (CHIPS) Trial (reporting: 2014) will guide non-severe hypertension management. Magnesium sulfate prevents and treats eclampsia; there is insufficient evidence to support alternative regimens. Pre-eclampsia predicts later cardiovascular disease; however, at this time we do not know what to do about it.

Citing Articles

Comparative Study of Coagulation Profile and Haematological Parameters in Pregnancy-Induced Hypertension (PIH).

Agarwal G, Agrawal A Cureus. 2024; 16(9):e70529.

PMID: 39479096 PMC: 11524649. DOI: 10.7759/cureus.70529.

Cerebroplacental Ratio as a Predictor of Perinatal Outcome in Hypertensive Disorders of Pregnancy and Its Comparison With Its Constituent Doppler Indices.

Malik N, Jain S, Ranjan R, Maurya D, Madan N, Singh U Cureus. 2024; 15(12):e49951.

PMID: 38179359 PMC: 10765206. DOI: 10.7759/cureus.49951.

Increased peripartum mortality associated with maternal subclinical malaria in Mozambique.

Jaen-Sanchez N, Gonzalez-Azpeitia G, Carranza-Rodriguez C, Manwere N, Garay-Sanchez P, Vallejo-Torres L Malar J. 2023; 22(1):182.

PMID: 37309000 PMC: 10258955. DOI: 10.1186/s12936-023-04613-3.

EZH2 enhances proliferation and migration of trophoblast cell lines by blocking GADD45A-mediated p38/MAPK signaling pathway.

Qian X, Zhang Y Bioengineered. 2022; 13(5):12583-12597.

PMID: 35609316 PMC: 9275956. DOI: 10.1080/21655979.2022.2074620.

Prevalence of Preeclampsia in Brazil: An Integrative Review.

Guida J, Andrade B, Pissinatti L, Rodrigues B, Hartman C, Costa M Rev Bras Ginecol Obstet. 2022; 44(7):686-691.

PMID: 35139578 PMC: 9948112. DOI: 10.1055/s-0042-1742680.

References

North R, Simmons D, Barnfather D, Upjohn M . What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia. Aust N Z J Obstet Gynaecol. 1996; 36(3):233-8. DOI: 10.1111/j.1479-828x.1996.tb02702.x. View

Gruslin A, Lemyre B . Pre-eclampsia: fetal assessment and neonatal outcomes. Best Pract Res Clin Obstet Gynaecol. 2011; 25(4):491-507. DOI: 10.1016/j.bpobgyn.2011.02.004. View

. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2005; 99(1):159-67. DOI: 10.1016/s0029-7844(01)01747-1. View

Askie L, Duley L, Henderson-Smart D, Stewart L . Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007; 369(9575):1791-1798. DOI: 10.1016/S0140-6736(07)60712-0. View

Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H . The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2011; 206(1):58.e1-8. DOI: 10.1016/j.ajog.2011.07.037. View

Schutte J, Schuitemaker N, Van Roosmalen J, Steegers E . Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG. 2008; 115(6):732-6. DOI: 10.1111/j.1471-0528.2008.01702.x. View

Gomez-Arriaga P, Herraiz I, Lopez-Jimenez E, Escribano D, Denk B, Galindo A . Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia. Ultrasound Obstet Gynecol. 2013; 43(5):525-32. DOI: 10.1002/uog.13224. View

Tranquilli A, Dekker G, Magee L, Roberts J, Sibai B, Steyn W . The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2015; 4(2):97-104. DOI: 10.1016/j.preghy.2014.02.001. View

Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J . Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002; 359(9321):1877-90. DOI: 10.1016/s0140-6736(02)08778-0. View

10.

Laskin S, Payne B, Hutcheon J, Qu Z, Douglas M, Ford J . The role of platelet counts in the assessment of inpatient women with preeclampsia. J Obstet Gynaecol Can. 2011; 33(9):900-8. DOI: 10.1016/s1701-2163(16)35015-0. View

11.

Menzies J, Magee L, Macnab Y, Ansermino J, Li J, Douglas M . Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy. 2007; 26(4):447-62. DOI: 10.1080/10641950701521742. View

12.

Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S . Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 2010; 33(5):422-7. DOI: 10.1038/hr.2010.15. View

13.

Firoz T, Melnik T . Postpartum evaluation and long term implications. Best Pract Res Clin Obstet Gynaecol. 2011; 25(4):549-61. DOI: 10.1016/j.bpobgyn.2011.03.003. View

14.

Benton S, Hu Y, Xie F, Kupfer K, Lee S, Magee L . Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am J Obstet Gynecol. 2011; 205(5):469.e1-8. DOI: 10.1016/j.ajog.2011.06.058. View

15.

Wen S, Kramer M, Hoey J, Hanley J, Usher R . Terminal digit preference, random error, and bias in routine clinical measurement of blood pressure. J Clin Epidemiol. 1993; 46(10):1187-93. DOI: 10.1016/0895-4356(93)90118-k. View

16.

Shammas A, Maayah J . Hypertension and its relation to renal function 10 years after pregnancy complicated by pre-eclampsia and pregnancy induced hypertension. Saudi Med J. 2001; 21(2):190-2. View

17.

Bar J, Kaplan B, Wittenberg C, Erman A, Boner G, Ben-Rafael Z . Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol Dial Transplant. 1999; 14(5):1129-32. DOI: 10.1093/ndt/14.5.1129. View

18.

Myers J, Kenny L, McCowan L, Chan E, Dekker G, Poston L . Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG. 2013; 120(10):1215-23. DOI: 10.1111/1471-0528.12195. View

19.

Gaugler-Senden I, Huijssoon A, Visser W, Steegers E, de Groot C . Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation. Audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol. 2005; 128(1-2):216-21. DOI: 10.1016/j.ejogrb.2005.11.011. View

20.

North R, McCowan L, Dekker G, Poston L, Chan E, Stewart A . Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ. 2011; 342:d1875. PMC: 3072235. DOI: 10.1136/bmj.d1875. View